Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in COVID-19 respiratory failure
NCT04340557Phase 4Completed
- Sponsor
- Sharp HealthCare
- Start
- Mar 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of losartan in coronavirus disease 2019 (COVID-19), sponsored by Sharp HealthCare. Started Mar 2020; status: completed.
02
Drugs
losartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04340557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04340557.